Non classé

Devictor J, Burnet E, Henriot T, Leclercq A, Ganne-Carrie N, Kilpatrick K, Jovic L Abstract Objectives: To examine the characteristics of the first Advanced Practice Nurses in France and to compare the French model to international standards. Background: Common barriers and facilitators to their integration in healthcare provision have been identified internationally. In France, the legislative framework was …

Implementing advanced practice nursing in France: A country-wide survey 2 years after its introduction Read More »

Azzi J, Dorival C, Cagnot C, Fontaine H, Lusivika-Nzinga C, Leroy V, De Ledinghen V, Tran A, Zoulim F, Alric L, Gournay J, Bronowicki JP, Decaens T, Riachi G, Mikhail N, Soliman R, Shiha G, Pol S, Carrat F, Ganne-Carrié N; ANRS-AFEF Hepather Study group. Abstract Background & aims: Prediction of hepatocellular carcinoma (HCC) occurrence in patients …

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response Read More »

Nguyen N, Rode A, Trillaud H, Aubé C, Manichon AF, Hocquelet A, Paisant A, Dao T, Nahon P, Ganne-Carrié N, Blaise L, Cauchy F, Sutter O, Séror O, Nault JC Liver International, Décembre 2021 Background & aims: Long-term outcomes after percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) have …

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease Read More »

Blaise L, Pereira H, Vilgrain V, Sutter O, Gigante E, Walter A, Ganne-Carrié N, Nahon P, Bouattour M, Dioguardi Burgio M, Grando V, Nkontchou G, Seror O, Nault JC.Clin Res Hepatol Gastroenterol. 2021 Abstract Introduction: We aim to assess the outcomes of percutaneous ablation of locally advanced HCC in a tertiary center, which is usually not indicated. …

Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion Read More »

Landemaine A, Hamdi-Roze H, Cunat S, Loustaud-Ratti V, Causse X, Si Ahmed SN, Drenou B, Bureau C, Pelletier G, De Kerguenec C, Ganne-Carrie N, Durupt S, Laine F, Loréal O, Ropert M, Detivaud L, Morcet J, Aguilar-Martinez P, Deugnier YM, Bardou-Jacquet E. Abstract Background and aims: Ferroportin disease (FD) is a rare genetic iron overload …

A simple clinical score to promote and enhance ferroportin disease screening Read More »